SLNO - CIK 0001484565
The table below shows SOLENO THERAPEUTICS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $133.03M | $246.66M | $76.50M | $81.33M | $48.41M | $57.02M |
| Short-term investments | $122.57M | $252.27M | $210.34M | $208.62M | $208.36M | $209.10M |
| Receivables | $47.14M | $25.51M | $24.62M | - | - | - |
| Inventory | $17.31M | $6.67M | $2.35M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $326.38M |
| $534.85M |
| $316.79M |
| $308.92M |
| $258.20M |
| $267.50M |
| Property, plant & equipment | $202.00K | $150.00K | $166.00K | $173.00K | $196.00K | $19.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $608.39M | $599.89M | $332.31M | $318.09M | $296.71M | $304.13M |
| Accounts payable | $12.39M | $8.14M | $6.22M | $5.48M | $6.24M | $3.72M |
| Total current liabilities | $58.05M | $33.25M | $20.94M | $15.73M | $14.96M | $9.15M |
| Long-term debt | $49.87M | $49.83M | $49.84M | $49.84M | - | - |
| Total liabilities | $112.59M | $105.09M | $92.17M | $85.83M | $32.01M | $23.37M |
| Retained earnings | -$399.99M | -$474.73M | -$500.74M | -$496.03M | -$396.28M | -$319.66M |
| Total equity | $495.80M | $494.81M | $240.14M | $232.26M | $264.70M | $280.76M |